Motolani E. Adedipe, DPh, Ph.D. is an Associate Professor in the Department of Family and Preventive Medicine at the University of Oklahoma Health Sciences Center. She has both clinical (DPh) and graduate (PhD) training in pharmacy. She earned her MSc and PhD degrees in Pharmaceutical Sciences from The University of Texas at Austin in 2014 and 2017, respectively.
Through her research, Dr. Adedipe aims to become an independent pharmacist researcher and leader who conducts community-engaged, mixed methods, and population-based cohort studies that focus on examining and building interventions around quality of life (QoL) issues relevant to underserved communities.
Dr. Adedipe’s research focuses on health economics and outcomes research using mixed methodologies. Her research interests primarily involve understanding health behaviors among underserved, minority groups and the use of patient-reported outcomes to capture disease burden in patients with rare diseases, cancer, and other disease conditions. Additional research interests include psychometrics (instrument development and validation) and examining QoL through theoretical frameworks and large-scale retrospective database analyses. She is currently developing a mHealth platform for Black prostate cancer survivors to improve their QoL and exploring socioeconomic influences on cutaneous lupus erythematosus diagnosis and outcomes
Education:
Degree-Granting Education:
- University of Lagos, Lagos, Nigeria
Postgraduate Education:
- Master of Science in Pharmaceutical Sciences, The University of Texas at Austin
- Doctor of Philosophy in Pharmaceutical Sciences, The University of Texas at Austin
- Doctor of Pharmacy, Oklahoma State Board of Pharmacy
Funding:
Validation of the Cutaneous Lupus Erythematosus Quality of Life (CLEQoL), a CLE-Specific Patient-Reported Outcome Measure.
W81XWH2210934
Role: Co-PI
09/30/2022 – 09/29/2024
Funding Agency: Department of Defense, IDEA Award
Development of a theory-based framework and measures of acculturation for African immigrants
1R15MD017012-01A1
Role: Co-PI
08/12/2022 – 07/31/2025
Funding Agency: Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15), NIMHHD
A pilot randomized clinical trial of a smartphone-based application for prostate cancer education and home-based PSA screening for African American men
Team Science Grant Award
Role: Co-I
07/01/2022 – 06/30/2023
Funding Agency: University of Oklahoma Health Sciences Center, Presbyterian Health Foundation
Mobile Prostate Cancer Survivorship App for Black Men: Pilot Study
R25MD011564
Role: PI
09/01/2021 – 05/31/2023
Funding Agency: NIMHHD
Quality of Life of Ethnically Diverse Black Prostate Cancer Survivors: Development of a Conceptual Model Using Grounded Theory
EIRAW81XWH-20-1-0080
Role: PI
06/30/2020 – 06/12/2023
Funding Agency: Department of Defense (DoD), Investigator Research Award
Select Publications:
- Ogunsanya ME, Sifat M, Bamidele OO, Ezenwankwo EF, Clifton S, Knight J, Odedina FT, Greer JA, Dwyer K, Kendzor D. Mobile Health (mHealth) Interventions in Prostate Cancer Survivorship – A Scoping Review. Journal of Cancer Survivorship. Epub ahead of print.
- Sifat MS, Ehlke SJ, Boozary LK, Alexander AC, Ogunsanya ME, Businelle MS, Kenzor DE. Greater Discrimination Frequency and Lower Distress Tolerance are Associated with Mental Problems among Racially Privileged and Minoritized Adults Accessing an Urban Day Shelter. Journal of Racial and Ethnic Health Disparities. Epub ahead of print.
- Iwuchukwu OF, Fadesere J, Ogunsanya ME, Griffo R. Do Brighter Personalities Matter? Relationship between Personality and Job Satisfaction in Working Pharmacists. American Journal of Pharmacotherapy and Pharmaceutical Sciences. 2022:1;9 DOI:10.25259/AJPPS_15_2022
- Walker MA, Lu G, Clifton S, Ogunsanya ME, Chong BF. Mitchell E. Influence of Socio-demographic Factors in Patients with Cutaneous Lupus Erythematosus. Frontiers in Medicine (Lausanne). 2022 Jul 11;9:916134. DOI: 10.3389/fmed.2022.916134. PMID: 35899206; PMCID: PMC9311297.
- Akin-Odanye EO, Ogunsanya ME, Lawal S, Sulaiman FA, Ogo CN. Resilience and Associated Factors in Men with Prostate Cancer. Journal of Positive Psychology and Counselling, June 2022 Vol. 10.
- Ezenwankwo EF, Nnate DA, Oladoyinbo CA, Dogo HM, Idowu AA, Onyeso CP, Ogo CN, Ogunsanya ME, Bamidele O, Nnaji CA. Strengthening Capacity for Prostate Cancer Early Diagnosis in West Africa Amidst the COVID-19 Pandemic: A Realist Approach to Rethinking and Operationalizing the World Health Organization 2017 Guide to Cancer Early Diagnosis. Annals of Global Health. 2022; 88(1): 29, 1–12. DOI: https://doi.org/10.5334/aogh.3519
- Bamidele OO, Alexis O, Ogunsanya ME, Greenley S, Worsley A, Mitchell E. Barriers and Facilitators to Accessing and Utilising Post-Treatment Psychosocial Support by Black Men Treated For Prostate Cancer – A Systematic Review and Qualitative Synthesis Prostate Cancer Survivors. Supportive Care in Cancer, 2022. DOI: https://doi.org/10.1007/s00520-021-06716-6
- Ezenwankwo EF, Ogbodo VE, Alom GO, Nwadilibe IB, Ofodum CM, Nwankwo CA, Okigbo CC, Omeje CA, Onyebuchi SJ, Oladoyimbo CA, Ezeani A, Akin-Odanye EO, Ogunsanya ME. Behavioural Oncology Research in Africa: Lessons From The Last Two Decades and Key Considerations Moving Forward. Eur J Cancer Care (Engl), 2021 Dec 21:e13545. doi: 10.1111/ecc.13545. Epub ahead of print. PMID: 34931724.
- Ogunsanya ME, Goetzinger E, Owopetu O, Chandler PD, O'Connor. Predictors of palliative care knowledge: Findings from the Health Information National Trends Survey. Cancer Epidemiology, Biomarkers & Prevention Journal, 2021 July;30(7):1433-1439; DOI: 10.1158/1055-9965.EPI-20-1790
- Swaby JA, Kaninjing E, Ogunsanya ME. African American Participation in Cancer Clinical Trials. Ecancer, 2021, 15(1307). DOI: https://doi.org/10.3332/ecancer.2021.1307
- Akin-Odanye EO, Ogo CN, Sulaiman FA, Lawal S, Ogunsanya ME, Odedina FT. Examining the Influence of Illness Perception and Financial Toxicity on the Quality of Life of Prostate Cancer Patients. African Journal of Urology, 2021, 27(72). DOI: https://doi.org/10.1186/s12301-021-00173-7
- Ogunsanya ME, Cho SK, Hudson A, Chong BF. Factors Associated with Quality of Life in Cutaneous Lupus Erythematosus Using the Revised Wilson and Cleary Model. Lupus Journal, 2020 Nov;29(13):1691-1703. DOI: https://doi.org/10.1177%2F0961203320951842
- Arriens C, Aberle T, Carthen F, Grant D, Kamp P, Kamp S, Thanou K, Chakravarty E, James JA, Merrill JT, Ogunsanya ME. Lupus Patient Decisions About Clinical Trial Participation: A Qualitative Evaluation of Perceptions, Facilitators, and Barriers. Lupus Science & Medicine, 2020 Mar 15;7(1):e000360. DOI: https://doi.org/10.1136/lupus-2019-000360
- Prasad S, Raman J, Ogunsanya ME, Chong BF. Principal Components Analysis as a Tool to Identify Lesional Skin Patterns in Cutaneous Lupus Erythematosus. Journal of the American Academy of Dermatology, 2020 Jan 12;S0190-9622(20)30053-0. DOI: https://doi:10.1016/j.jaad.2020.01.010
- Faruk M, Odedina FT, Ibrahim S, Ogunsanya ME, Ugwumba F, Mbadiwe O, et al. Cortisol and Health-Related Quality of Life as Prognostic Indicators for Prostate Cancer Risk in West African Black Men in Nigeria, Cameroon and the USA: The CaPTC Cohort Study. Cancer Health Disparities Journal, 2019.
- Oladoyinbo CA, Akinbule OO, Bolajoko OA, Aheto JMK, Dagne G, Mohamed F, Bassey IE, Odedidna FT, Agaba R, Askins N, Ogunlana OO, Ogunsanya ME, Suleiman AM, Anyanwu SO, Gali RM, Kaninjing E, Nkegoum B, Omonisi A, Sowunmi A, Jibrin P, Iweala EE, Fatiregun O, Popoola AA. Risk Factors for Prostate Cancer in West African Men: The Familial Cohort Study. Cancer Health Disparities Journal, 2019. DOI: https://doi:10.9777/chd.2019.1007
- Ogunsanya ME, Bassey IE, Faruk M, Oladoyinbo C, Nggada H, Omonisi A, Askins NA, Nkegoum B, Popoola AA, Okpala I, Fatiregun O, Jibrin P, Iweala EE, Kukoyi W, Adeniji K, Salako A, Sowunmi A, Odedina FT. Perceived Behavioral Control regarding Prostate Cancer Screening among Black Men in West Africa and the United States. Cancer Health Disparities Journal, 2019. DOI: https://doi:10.9777/chd.2019.1006
- Bassey IE, Theophilus I, Ugbem I, Uwem OA, Anyanwu S, Enakirerhi EG, Gali RM, Oladoyinbo C, Omonisi A, Dagne G, Kaninjing TE, Askins NA, Ogunsanya ME, Mohamed F, Idowu AA, Odedina FT. Overcoming Barriers in Conducting a Transatlantic Prostate Cancer Familial Study in Africa: Best Practice from the CaPTC Cohort Study. Cancer Health Disparities Journal, 2019. DOI: https://doi:10.9777/chd.2019.1001
- Ogunsanya ME, Odedina FT, Kaninjing E, Atawodi SE, Akinremi T, Sowunmi A. Prostate Cancer Risk-Reduction Behaviors among US Black Males Less Than 40 Years Old. Cancer Health Disparities Journal, 2019. DOI: https://doi:10.9777/chd.2019.1004
- Ogunsanya ME1, Hudson AD, Cho SK, Chong BF. Validation and Reliability of a Disease‐Specific Quality of Life Measure in Patients with Cutaneous Lupus Erythematosus: CLEQoL. British Journal of Dermatology, 2019, 180(6): 1430-1437. DOI: https://doi.org/10.1111/bjd.17636
- Dickey SL, Ogunsanya ME. Quality of Life among Black Prostate Cancer Survivors. American Journal of Men’s Health, 2018, 12(5):1648-1664.
- Ogunsanya ME, Brown CM, Lin D, Imarhia F, Maxey C, Chong BF. Understanding the Disease Burden and Unmet Needs among Patients with Cutaneous Lupus Erythematosus (CLE): A Qualitative Study. International Journal of Women’s Dermatology, 2018, 4(3): 152-158.
- Ogunsanya ME, Nduaguba SO, Brown CM. Incremental Health Care Services and Expenditures Associated with Depression among Individuals with Cutaneous Lupus Erythematosus (CLE). Lupus, 2018, 27(7):1107-1115.
- Ogunsanya ME, Bamgbade B, Thach AV, Sudhapalli P, Rascati K. Determinants of Health-Related Quality of Life in International Graduate Students. Currents in Pharmacy Teaching and Learning, 2018, 10(4):413-422. DOI: https://doi.org/10.1016/j.cptl.2017.12.005